Posts Tagged Huntington’s Disease

Medical Center researchers were instrumental in the U.S. Food and Drug Administration’s recent approval of SD-809 (deutetrabenazine) to treat Huntington’s disease.

A new grant anticipated to total more than $10.5 million over next five years will help Medical Center scientists develop a stem cell-based therapy that swaps sick brain cells for healthy ones.

Medical Center researchers have successfully reduced the symptoms and slowed the progression of Huntington’s disease by replacing sick mouse glia cells with healthy human cells. The findings could ultimately point to a new method to treat the disease.